View Kiniksa Pharmaceuticals International, plc Class A KNSA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) was quite a hit on our domestic stock exchange in Tuesday's trading session. It released its inaugural 2026 earnings report and, with key ...

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here's what investors need to know before the announcement. Analysts estimate that ...

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is preparing to release its quarterly earnings on Tuesday, 2025-10-28. Here's a brief overview of what investors should keep in mind before the announcement.

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement. Analysts estimate that ...

Explore the exciting world of Kiniksa Pharmaceuticals (NASDAQ: KNSA) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market ...

Kiniksa Pharmaceuticals is gaining momentum after strong ARCALYST sales growth, raised revenue guidance, and optimism ...

Kiniksa transitions from survival risk to growth, targeting dominance in the pericarditis market with robust cash flow and expanding margins. KNSA's Arcalyst drives revenue growth, with 2026 guidance ...

The biotech delivered a beat-and-raise first quarter.